Ibragimova, M. K., Tsyganov, M. M., Kravtsova, E. A., & Litviakov, N. V. (2024). Changes in the Expression Landscape of HER2-Negative Breast Cancer under the Influence of Anthracycline-Containing Neoadjuvant Chemotherapy Regimens. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18(4), 368-382. https://doi.org/10.1134/s1990750824600559
Chicago Style (17th ed.) CitationIbragimova, M. K., M. M. Tsyganov, E. A. Kravtsova, and N. V. Litviakov. "Changes in the Expression Landscape of HER2-Negative Breast Cancer Under the Influence of Anthracycline-Containing Neoadjuvant Chemotherapy Regimens." Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 18, no. 4 (2024): 368-382. https://doi.org/10.1134/s1990750824600559.
MLA (9th ed.) CitationIbragimova, M. K., et al. "Changes in the Expression Landscape of HER2-Negative Breast Cancer Under the Influence of Anthracycline-Containing Neoadjuvant Chemotherapy Regimens." Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, vol. 18, no. 4, 2024, pp. 368-382, https://doi.org/10.1134/s1990750824600559.